Short-term effects of angiotensin receptor blockers on blood pressure control, and plasma inflammatory and fibrinolytic parameters in patients taking angiotensin-converting enzyme inhibitors.

about

Short-term effects of angiotensin receptor blockers on blood pressure control, and plasma inflammatory and fibrinolytic parameters in patients taking angiotensin-converting enzyme inhibitors.

Item

http://www.wikidata.org/entity/Q46650583

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

Short-term effects of angioten ...... -converting enzyme inhibitors.

@en

Short-term effects of angioten ...... -converting enzyme inhibitors.

@nl

type

Item

label

Short-term effects of angioten ...... -converting enzyme inhibitors.

@en

Short-term effects of angioten ...... -converting enzyme inhibitors.

@nl

prefLabel

Short-term effects of angioten ...... -converting enzyme inhibitors.

@en

Short-term effects of angioten ...... -converting enzyme inhibitors.

@nl

P1476

Short-term effects of angioten ...... -converting enzyme inhibitors.

@en

P2093

Altug Cincin

http://www.w3.org/2001/XMLSchema#string

Mehmet Agirbasli

http://www.w3.org/2001/XMLSchema#string

Oytun A Baykan

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group.

Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group.

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.

A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial.

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials.

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

P304

22-26

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3317/JRAAS.2008.004

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2008-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5447283

http://www.w3.org/2001/XMLSchema#string

P698

18404606

http://www.w3.org/2001/XMLSchema#string